Price $129.68 |
Market Cap
2.79B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
35.8
|
P/B
1.97
|
P/S
1.85
|
Dividend %
-
|
|
P/CF
241.7
|
P/FCF
47.2
|
Op. Cash Flow
176.2K
|
FCF
1.8
|
|
Op. Margin
10.00%
|
Net Margin
5.30%
|
ROE
5.70%
|
ROI
4.70%
|
|
ROA
2.90%
|
EPS Growth
13.70%
|
Current Ratio
2.5
|
Debt/Equity
64.60%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Myomo Inc (MYO) | $3.77 | - | - | 35.8M | Strong Buy |
| iCAD Inc (ICAD) | $1.51 | - | - | 38.2M | Strong Buy |
| PetIQ Inc (PETQ) | $30.58 | - | - | 564.3M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $2.73 | - | - | 183.6M | Strong Buy |
| Generation Bio Co (GBIO) | $2.32 | - | - | 65.9M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
